Cargando…

In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

Ruthenium complexes offer the potential of reduced toxicity, a novel mechanism of action, non-cross resistance and a different spectrum of activity compared to platinum containing compounds. Thirteen novel ruthenium(II) organometallic arene complexes have been evaluated for activity (in vitro and in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aird, R E, Cummings, J, Ritchie, A A, Muir, M, Morris, R E, Chen, H, Sadler, P J, Jodrell, D I
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746580/ https://www.ncbi.nlm.nih.gov/pubmed/12085218 http://dx.doi.org/10.1038/sj.bjc.6600290

Ejemplares similares

Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes
por: Hanif, Muhammad, et al.
Publicado: (2013)

Organometallic cis-Dichlorido Ruthenium(II) Ammine Complexes
por: Betanzos-Lara, Soledad, et al.
Publicado: (2011)

Cell Death Mechanism of Organometallic Ruthenium(II) and Iridium(III) Arene Complexes on HepG2 and Vero Cells
por: Kavukcu, Serdar Batıkan, et al.
Publicado: (2023)

Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes
por: Carter, R, et al.
Publicado: (2016)

Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes
por: Khater, Mai, et al.
Publicado: (2022)

Photorelease of Pyridyl Esters in Organometallic Ru(II) Arene Complexes
por: Habtemariam, Abraha, et al.
Publicado: (2015)

Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity
por: Gatti, Anna, et al.
Publicado: (2018)

Light Triggers the Antiproliferative Activity of Naphthalimide-Conjugated (η(6)-arene)ruthenium(II) Complexes
por: Bisceglie, Franco, et al.
Publicado: (2022)

The Application of Reversible Intramolecular Sulfonamide Ligation to Modulate Reactivity in Organometallic Ruthenium(II) Diamine Complexes
por: Kemp, Samuel A., et al.
Publicado: (2020)

Mirror-Image Organometallic Osmium Arene Iminopyridine Halido Complexes Exhibit Similar Potent Anticancer Activity
por: Fu, Ying, et al.
Publicado: (2013)

A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
por: Hsia, Chih-Hsuan, et al.
Publicado: (2017)

Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites
por: de Souza, Nicolli Bellotti, et al.
Publicado: (2015)

Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights
por: Marras, Emanuela, et al.
Publicado: (2023)

Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo
por: Bapiro, T E, et al.
Publicado: (2014)

Reactivity of non-organometallic ruthenium(II) polypyridyl complexes and their application as catalysts for hydride transfer reactions
por: Chrzanowska, Marta, et al.
Publicado: (2023)

Surface-Bound Ruthenium Diimine Organometallic Complexes: Excited-State Properties
por: Abbott, Geoffrey, et al.
Publicado: (2014)

Mechanistic Studies of Arene–Ruthenium(II) Complexes with Carbothioamidopyrazoles as Alternative Cancer Drugs
por: Hikisz, Paweł, et al.
Publicado: (2023)

Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg(6),D-Trp(7,9),N(me)Phe(8)]-substance P (6–11)-induced growth inhibition
por: Waters, C M, et al.
Publicado: (2003)

Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate Ligands
por: Allison, Matthew, et al.
Publicado: (2023)

Author Correction: A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
por: Hsia, Chih-Hsuan, et al.
Publicado: (2020)

Fine-tuning the cytotoxicity of ruthenium(ii) arene compounds to enhance selectivity against breast cancers
por: Pereira, Sarah A. P., et al.
Publicado: (2023)

Half-Sandwich Arene Ruthenium(II) Thiosemicarbazone Complexes: Evaluation of Anticancer Effect on Primary and Metastatic Ovarian Cancer Cell Lines
por: Guler, Seminay, et al.
Publicado: (2022)

Nanoscaled carborane ruthenium(II)-arene complex inducing lung cancer cells apoptosis
por: Zhang, Gen, et al.
Publicado: (2011)

Arene-Ruthenium(II) Complexes with Carbothiamidopyrazoles as a Potential Alternative for Antibiotic Resistance in Human
por: Namiecińska, Ewelina, et al.
Publicado: (2022)

In Vitro and In Vivo Biological Activity of Ruthenium 1,10-Phenanthroline-5,6-dione Arene Complexes
por: Lenis-Rojas, Oscar A., et al.
Publicado: (2022)

Exploring pta Alternatives in the Development of Ruthenium–Arene Anticancer Compounds
por: Kljun, Jakob, et al.
Publicado: (2023)

Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
por: Morbidelli, L, et al.
Publicado: (2003)

Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity
por: Liu, Suyan, et al.
Publicado: (2018)

Ruthenium(II)(η(6)-arene) Complexes of Thiourea Derivatives: Synthesis, Characterization and Urease Inhibition
por: Hanif, Muhammad, et al.
Publicado: (2014)

Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization
por: Cuccioloni, Massimiliano, et al.
Publicado: (2022)

Synthesis and Antiparasitic Activity of New Trithiolato-Bridged Dinuclear Ruthenium(II)-arene-carbohydrate Conjugates
por: Holzer, Isabelle, et al.
Publicado: (2023)

Enhancing the Activity of Drugs by Conjugation to Organometallic Fragments
por: Chellan, Prinessa, et al.
Publicado: (2020)

Ruthenium(II)-catalysed remote C–H alkylations as a versatile platform to meta-decorated arenes
por: Li, Jie, et al.
Publicado: (2017)

Arene Variation of Highly Cytotoxic Tridentate Naphthoquinone-Based Ruthenium(II) Complexes and In-Depth In Vitro Studies
por: Cseh, Klaudia, et al.
Publicado: (2022)

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)
por: Sewell, J M, et al.
Publicado: (2002)

MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity
por: Cebulla, J, et al.
Publicado: (2015)

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
por: Sims, A H, et al.
Publicado: (2012)

Coumarin‐Tagged Dinuclear Trithiolato‐Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity
por: Desiatkina, Oksana, et al.
Publicado: (2020)

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
por: Lorusso, D, et al.
Publicado: (2012)

In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring
por: Zhong, W, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7es7n1d0likt8ipf1fh87pcvmh